Wolfe Josh
Insider CIK 1830001 · RXRX · SHPW Director, 10% owner · AEVA 10% owner · SNCE 10% owner · MTTR 10% owner · LUXA 10% owner · LTCH 10% owner · EIKN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 796,380 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 2,502,252 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 7,807,026 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 530,920 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 3,526,215 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 303,360 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 1,450,614 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,266,152 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 5,289,322 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,000,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,266,152 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 1,450,614 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 303,360 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 3,526,215 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 5,289,322 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 530,920 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 796,380 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 2,502,252 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 7,807,026 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,000,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,387,705 | — | $0 | 2,387,705 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 1,151,540 | — | $0 | 1,290,428 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,155,765 | — | $0 | 2,294,653 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,387,705 | — | $0 | 2,387,705 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 1,151,540 | — | $0 | 1,290,428 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,155,765 | — | $0 | 2,294,653 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 62,500 | — | $0 | 62,500 | SEC↗ |
| AEVA Aeva Technologies, Inc. | J Other | 2022-08-05 | 2022-08-09 | 7,346,159 | — | $0 | 14,692,316 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2022-06-08 | 2022-06-10 | 31,250 | — | $0 | 31,250 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | J Other | 2022-04-04 | 2022-04-06 | 2,914,667 | — | $0 | 8,743,999 | SEC↗ |
| MTTR Matterport, Inc./DE | J Other | 2022-01-18 | 2022-01-21 | 6,306,411 | — | $0 | 18,919,230 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-12-07 | 2021-12-09 | 4,265,576 | — | $0 | 13,021,519 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 155,400 | — | $0 | 155,400 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 284,846 | — | $0 | 284,846 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 2,563,614 | — | $0 | 2,563,614 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 381,111 | — | $0 | 381,111 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 3,430,000 | — | $0 | 3,430,000 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 300,000 | $10.00 | $3.00M | 300,000 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 181 | — | $0 | 181 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 1,633 | — | $0 | 1,633 | SEC↗ |
| SHPW Shapeways Holdings, Inc. | A Award | 2021-09-29 | 2021-10-01 | 17,267 | — | $0 | 17,267 | SEC↗ |
| LTCH Latch, Inc. | J Other | 2021-09-28 | 2021-10-05 | 1,358,164 | — | $0 | 4,084,493 | SEC↗ |
| LTCH Latch, Inc. | J Other | 2021-09-28 | 2021-10-05 | 2,409,489 | — | $0 | 7,228,469 | SEC↗ |
| AEVA Aeva Technologies, Inc. | J Other | 2021-09-08 | 2021-09-10 | 7,346,159 | — | $0 | 22,038,475 | SEC↗ |
| LUXA Lux Health Tech Acquisitio | P Buy deriv | 2020-10-29 | 2020-11-02 | 5,933,333 | $1.50 | $8.90M | 5,933,333 | SEC↗ |